{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T05:03:56Z","timestamp":1779685436769,"version":"3.53.1"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Many patients report adverse symptoms following wheat\/gluten consumption. As \u201cSelf-Reported Wheat\/Gluten Sensitivity\u201d lacks gold-standard biomarkers, characterizing biological profiles in Western populations is essential for precision management. This study analyzes immunogenetic (HLA-DQ) and serological (IgG) patterns in a real-world clinical cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A retrospective observational study used Real-World Evidence (RWE) from 100 symptomatic individuals (2019\u20132024) selected via non-probabilistic convenience sampling. Participants underwent HLA-DQ genotyping and serum IgG reactivity testing for wheat\/gluten via a validated ELISA-based assay. Data normality was formally assessed using the Shapiro-Wilk test, revealing a non-parametric distribution (\n                      <jats:italic>W=0.59, p&amp;lt;0.001<\/jats:italic>\n                      ). Consequently, inferential analyses included Chi-square (\n                      <jats:italic>X<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      ) tests for categorical associations, Spearman\u2019s rank correlation (\n                      <jats:italic>\n                        r\n                        <jats:sub>s<\/jats:sub>\n                      <\/jats:italic>\n                      ), and Odds Ratio (OR) calculations with 95% Confidence Intervals (95% CI).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A 100% cumulative frequency of HLA-DQ susceptibility variants was observed. The immunogenetic landscape revealed complex heterozygosity: DQ1 was most prevalent (56%), followed by DQ2 (54%), DQ3 (40%), and DQ8 (33%). DQ8 (\n                      <jats:italic>\n                        X\n                        <jats:sup>2<\/jats:sup>\n                        \u00a0=\u00a010.24; p=0.001\n                      <\/jats:italic>\n                      ) and DQ3 (\n                      <jats:italic>\n                        X\n                        <jats:sup>2<\/jats:sup>\n                        \u00a0=\u00a04.84; p=0.028\n                      <\/jats:italic>\n                      ) were significant markers. Specific IgG reactivity occurred in 68% of cases, showing strong wheat-gluten correlation\n                      <jats:italic>\n                        (r\n                        <jats:sub>s<\/jats:sub>\n                        =0.887; p&amp;lt;0.001\n                      <\/jats:italic>\n                      ) and extraordinary cross-reactivity (\n                      <jats:italic>OR=88.2; 95% CI: 25.8\u2013301.4; p&amp;lt;0.001).<\/jats:italic>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Findings reveal a ubiquitous HLA-DQ frequency, suggesting a consistent genetic background in symptomatic individuals that significantly exceeds prevalence in the general Western population. This enriched 'mosaic' may facilitate immune activation. Furthermore, the observed IgG cross-reactivity validates the 'wheat\/gluten complex' as a synchronized immunological unit, supporting a transition toward biomarker-informed nutrition in real-world settings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1814097","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T04:44:18Z","timestamp":1779684258000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Immunogenetic HLA-DQ and IgG serological profiles in individuals with self-reported wheat\/gluten sensitivity: a retrospective real-world evidence study"],"prefix":"10.3389","volume":"17","author":[{"given":"Andreina","family":"White","sequence":"first","affiliation":[{"name":"Universidad Central de Venezuela (UCV)","place":["Caracas, Venezuela"]},{"name":"Autonomous University of Barcelona","place":["Barcelona, Spain"]},{"name":"University of Barcelona","place":["Barcelona, Spain"]},{"name":"NutriWhite Headquarters","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Verzura","sequence":"additional","affiliation":[{"name":"Universidad de Carabobo (UC)","place":["Valencia, Venezuela"]},{"name":"Venezuelan Institute for Scientific Research (IVIC)","place":["Caracas, Venezuela"]},{"name":"National Association of Nutritional Professionals","place":["Berkeley, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"White","sequence":"additional","affiliation":[{"name":"NutriWhite \u2013 International Organization of Immune Nutrition Specialists","place":["Pompano Beach, FL, United States"]},{"name":"Universidad Sim\u00f3n Bol\u00edvar (USB)","place":["Caracas, Venezuela"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Rodr\u00edguez","sequence":"additional","affiliation":[{"name":"NutriWhite Headquarters","place":["Caracas, Venezuela"]},{"name":"Regis College","place":["Weston, MA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"White","sequence":"additional","affiliation":[{"name":"Department of Assistance and Nutrition, School of Nutrition and Dietetics, Faculty of Medicine, University of Los Andes (ULA)","place":["M\u00e9rida, Venezuela"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milaidi","family":"Garc\u00eda Bravo","sequence":"additional","affiliation":[{"name":"Department of Assistance and Nutrition, School of Nutrition and Dietetics, Faculty of Medicine, University of Los Andes (ULA)","place":["M\u00e9rida, Venezuela"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-10-13","article-title":"Spectrum of gluten-related disorders: consensus on new nomenclature and classification","volume":"10","author":"Sapone","year":"2012","journal-title":"BMC Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1186\/s12876-020-01390\u20130","article-title":"An updated overview of spectrum of gluten-related disorders: clinical and diagnostic aspects","volume":"20","author":"Taraghikhah","year":"2020","journal-title":"BMC Gastroenterol"},{"key":"B3","first-page":"881","article-title":"Intestinal permeability in celiac disease and non-celiac gluten sensitivity: insights for clinical management","volume":"13","author":"Pinto-S\u00e1nchez","year":"2024","journal-title":"Nutrients"},{"key":"B4","doi-asserted-by":"publisher","first-page":"69","DOI":"10.12688\/f1000research.20510.1","article-title":"All disease begins in the (leaky) gut: role of zonulin-mediated gut permeability in the pathogenesis of some chronic inflammatory diseases","volume":"9","author":"Fasano","year":"2020","journal-title":"F1000Res"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.872345","article-title":"Genetic predisposition to wheat and gluten sensitivity: expanding HLA beyond DQ2\/DQ8","volume":"13","author":"Gnodi","year":"2022","journal-title":"Front Immunol"},{"key":"B6","article-title":"World health statistics 2020","year":"2020"},{"key":"B7","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/S0140-6736(17)31796-8","article-title":"Coeliac disease","volume":"391","author":"Lebwohl","year":"2018","journal-title":"Lancet"},{"key":"B8","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.3390\/nu12061832","article-title":"Effect of gluten-free diet on gut microbiota composition in patients with celiac disease and non-celiac gluten\/wheat sensitivity","volume":"12","author":"Caio","year":"2020","journal-title":"Nutrients"},{"key":"B9","doi-asserted-by":"crossref","DOI":"10.1016\/j.gastrohep.2022.10.001","article-title":"Sensibilidad al gluten no cel\u00edaca: etiolog\u00eda, diagn\u00f3stico diferencial y presentaci\u00f3n cl\u00ednica","volume":"46","author":"Exp\u00f3sito Miranda","year":"2023","journal-title":"Gastroenterol Hepatol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects","volume":"310","year":"2013","journal-title":"JAMA"},{"key":"B11","article-title":"Gluten sensitivity gene analysis: molecular analysis of DQA1 and DQB1 genotypes","year":"2020"},{"key":"B12","article-title":"Clinical laboratory improvement amendments (CLIA) of 1988","year":"1988"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2020.06.021","article-title":"Synthetic control arms can leverage external data to bridge the gap between real-world evidence and randomized controlled trials","volume":"126","author":"Thorlund","year":"2020","journal-title":"J Clin Epidemiol"},{"key":"B14","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/978-981-99-9029-0_2","article-title":"Autoimmune diseases: recent insights on epidemiology, pathogenesis, and prevalence rate","volume-title":"Artificial intelligence and autoimmune diseases","author":"Nautiyal","year":"2024"},{"key":"B15","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(23)00457-9","article-title":"Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK","volume":"401","author":"Conrad","year":"2023","journal-title":"Lancet"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1172\/JCI178722","article-title":"Estimation of prevalence of autoimmune diseases in the United States using electronic health record data","volume":"135","author":"Abend","year":"2024","journal-title":"J Clin Invest"},{"key":"B17","article-title":"Malnutrition in women","year":"2024"},{"key":"B18","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s12916-025-04044-8","article-title":"Diagnosis of celiac disease on a gluten-free diet: a multicenter prospective quasi-experimental clinical study","volume":"23","author":"G\u00f3mez-Aguililla","year":"2025","journal-title":"BMC Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"5083","DOI":"10.3390\/nu15245083","article-title":"Dynamics of serologic change to gluten in celiac disease patients","volume":"15","author":"Syage","year":"2023","journal-title":"Nutrients"},{"key":"B20","volume-title":"Considerations for the use of real-world data and real-world evidence to support regulatory decision-making for drug and biological products","year":"2023"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2024-0034","article-title":"HLA-DQ markers in healthy and symptomatic cohorts: A comparative analysis","author":"Gambino","year":"2024","journal-title":"Clin Chem Lab Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41435-019-0082-2","article-title":"The role of HLA-DQ molecules in celiac disease","volume":"21","author":"Sollid","year":"2020","journal-title":"Genes Immun"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.08.049","article-title":"Recent advances in the prevention and diagnosis of celiac disease","volume":"160","author":"Tye-Din","year":"2021","journal-title":"Gastroenterology"},{"key":"B24","first-page":"101696","article-title":"Non-celiac wheat sensitivity: Differential diagnosis, pathophysiology and nutritional management","author":"Schuppan","year":"2020","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1080\/10408398.2019.1651601","article-title":"Gluten-related disorders: Celiac disease, wheat allergy, and non-celiac gluten sensitivity","volume":"60","author":"Cabanillas","year":"2022","journal-title":"Crit Rev Food Sci Nutr"},{"key":"B26","doi-asserted-by":"crossref","first-page":"575844","DOI":"10.3389\/fnut.2020.575844","article-title":"Non-HLA genetic variants and innate immune activation in non-celiac wheat sensitivity","volume":"7","author":"Sallese","year":"2020","journal-title":"Front Nutr"},{"key":"B27","doi-asserted-by":"publisher","first-page":"4000","DOI":"10.1007\/978-3-030-16928-2_18","article-title":"Neurological manifestations of gluten sensitivity: a comprehensive review","volume":"13","author":"Zis","year":"2021","journal-title":"Nutrients"},{"key":"B28","first-page":"20","article-title":"Cross-reaction between gliadin and different food and tissue antigens","volume":"4","author":"Vojdani","year":"2013","journal-title":"Food Nutr Sci"},{"key":"B29","first-page":"1121","article-title":"Wheat amylase-trypsin inhibitors (ATIs) as primary drivers of non-celiac cereal sensitivity","volume":"10","author":"Schuppan","year":"2023","journal-title":"Front Nutr"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2020.00192","article-title":"Gluten proteins and immunogenic peptides: impact of environmental factors during grain development","volume":"7","author":"Ribeiro","year":"2020","journal-title":"Front Nutr"},{"key":"B31","unstructured":"Grain Free Research: 19 gluten cross-reactive foods: busted myth\n          \n          \n            \n              Graves\n              C\n            \n            \n              Pendergrass\n              K\n            \n          \n          \n          2016"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.rgmx.2021.06.009","article-title":"Papel de los alelos HLA-DQB1 en el riesgo, signos y s\u00edntomas y gravedad de la enfermedad cel\u00edaca en la poblaci\u00f3n venezolana","volume":"88","author":"Fern\u00e1ndez-Mestre","year":"2023","journal-title":"Rev Gastroenterol Mex"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1814097\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T04:44:35Z","timestamp":1779684275000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1814097\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,25]]},"references-count":32,"alternative-id":["10.3389\/fimmu.2026.1814097"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1814097","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,25]]},"article-number":"1814097"}}